CoChat

Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis

Bhagavan, Chiranth, Kung, Stacey, Doppen, Marjan, John, Mary, Vakalalabure, Iva, Oldfield, Karen, Braithwaite, Irene, Newton-Howes, Giles · 2020 · CNS Drugs
Cited by 45

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40263-020-00773-x

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 33

  1. American Psychiatric Association. (Institution), American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM–5). 2012. · DOI · Paper page
  2. Macêdo P, Neves G, Poyares DLRD, da Gomes MMM, Macedo P, Neves G, et al. Insomnia current diagnosis: an appraisal. Rev Bras Neurol. 2015;51:62–8.
  3. Bollu P, Kaur H. Sleep medicine: insomnia and sleep. Mo Med. 2019;116(1):68–75.
  4. Bjorøy I, Jørgensen VA, Pallesen S, Bjorvatn B. The prevalence of insomnia subtypes in relation to demographic characteristics, anxiety, depression, alcohol consumption and use of hypnotics. Front Psychol. 2020;11:527. · DOI
  5. Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3:3–6.
  6. Stoller MK. Economic effects of insomnia. Clin Ther. 1994;16:873–97.
  7. Cheung J, Ji X, Morin CM. Cognitive behavioral therapies for insomnia and hypnotic medications: considerations and controversies. Sleep Med Clin. 2019;14:253–65. · DOI
  8. Babson KA, Bonn-Miller MO. Sleep disturbances: implications for cannabis use, cannabis use cessation, and cannabis use treatment. Curr Addict Rep. 2014;1:109–14. · DOI
  9. Murillo-Rodríguez E. The role of the CB1 receptor in the regulation of sleep. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32:1420–7. · DOI
  10. Kesner AJ, Lovinger DM. Cannabinoids, endocannabinoids and sleep. Front Mol Neurosci. 2020;13:125. · DOI
  11. Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Δ-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24:305–13. · DOI · Paper page
  12. Léger D, Debellemaniere E, Rabat A, Bayon V, Benchenane K, Chennaoui M. Slow-wave sleep: from the cell to the clinic. Sleep Med Rev. 2018;41:113–32. · DOI · Paper page
  13. Prospero-Garcia O, Amancio-Belmont O, Becerril-Melendez A, Ruiz-Contreras A, Mendez-Diaz M. Endocannabinoids and sleep. Neurosci Biobehav Rev. 2016;71:671–9. · DOI
  14. Garcia AN, Salloum IM. Polysomnographic sleep disturbances in nicotine, caffeine, alcohol, cocaine, opioid, and cannabis use: a focused review. Am J Addict. 2015;24:590–8. · DOI · Paper page
  15. Linares IMP, Guimaraes FS, Eckeli A, Crippa ACS, Zuardi AW, Souza JDS, et al. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study. Front Pharmacol. 2018;9:1–8. · DOI · Paper page
  16. Pertwee RG, Ross RA, Craib SJ, Thomas A. (−)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens. Eur J Pharmacol. 2002;456:99–106. · DOI
  17. Carlini E, Cunha J. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981;21:417S-427S. · DOI · Paper page
  18. Zuardi AW, Guimaraes FS, Moreira AC. Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz J Med Biol Res Rev Bras Pesqui Med Biol. 1993;26:213–7.
  19. Bridgeman MBM, Abazia DDT. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. Pharm Ther. 2017;42:180–8.
  20. Walsh Z, Callaway R, Belle-isle L, Capler R, Kay R, Lucas P, et al. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int J Drug Policy. 2013;24:511–6. · DOI · Paper page
  21. Kuhathasan N, Dufort A, Mackillop J, Gottschalk R, Minuzzi L, Frey BN. The use of cannabinoids for sleep: a critical review on clinical trials. Exp Clin Psychopharmacol. 2019;27:383–401. · DOI · Paper page
  22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). 2013. · DOI · Paper page
  23. Buysse C, Reynolds F, Ill DJ, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–5. · DOI · Paper page
  24. Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19. · DOI · Paper page
  25. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. · DOI · Paper page
  26. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307. · DOI · Paper page
  27. Smith S, Trinder J. Detecting insomnia: comparison of four self-report measures of sleep in a young adult population. J Sleep Res. 2001;10:229–35. · DOI · Paper page
  28. Parrott AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations—a review. Psychopharmacology. 1980;71:173–9. · DOI · Paper page
  29. Duval S, Tweedie R. A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95:89–98.
  30. Cousens K, DiMascio A. Delta-9 THC as an hypnotic—an experimental study of three dose levels. Psychopharmacologia. 1973;33:355–64. · DOI
  31. Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18–041. · DOI · Paper page
  32. Capano A, Weaver R, Burkman E. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgrad Med. 2020;132:56–61. · DOI · Paper page
  33. Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A. Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder. Clin Drug Investig. 2014;34:587–91. · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Bhagavan, C., Kung, S., Doppen, M., John, M., Vakalalabure, I., Oldfield, K., Braithwaite, I., & Newton-Howes, G.
Venue
CNS Drugs
Published
2020-11-26
Volume
34
Issue
12
Pages
1217-1228
ISSN
  • 1172-7047
  • 1179-1934
Cited by
45
References
18
Language
en
Licence
Funders
Health Research Council of New Zealand (18/1002, 20/057)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.